Thrombin
Thrombin(凝血酶)
Thrombin is a Na+ -activated allosteric serine protease that catalyzes the formation of thrombus as well as a series of flux-regulating reactions through the coagulation cascade. In response to vascular injury, thrombin is produced through the activation of its inactive precursor, prothrobin, catalyzed by Factor Xa (a trypsin-like proteinase). As a serine protease characterized by the presence of a catalytic triad, thrombin possess a triad of S195-H57-D189 in its active center, which is required for the nucleophilic attack of the target peptide bond. Located “south-west” of the active center is a Na+ -binding site, through which the binding of a sodium ion allosterically modulates the activity of the serine proteinase.
Thrombin 相关产品(44)
- GC10140Thrombin Receptor Agonist PeptideCAS: 137339-65-2
A peptide agonist of the α-thrombin receptor
- GC17726OtamixabanCAS: 193153-04-7纯度: >98.50%
Otamixaban(FXV673) 是一种有效的 (Ki = 0.5 nM)、选择性、快速作用、竞争性和可逆的 fXa 抑制剂,可有效抑制游离和凝血酶原结合的 fXa。
- GC19766Heparin sodium salt (MW 15kDa)CAS: 9041-08-1纯度: >99.50%
肝素钠盐(MW 15kDa)(Sodium heparin (MW 15kDa))是肝素的聚合物,分子量为15kDa。
- GC32554Inogatran (H-314-27)CAS: 155415-08-0
Inogatran (H-314-27) (H-314-27) 是一种合成凝血酶抑制剂,用于治疗和预防动脉和静脉血栓性疾病。
- GC32567RWJ-445167 (3DP-10017)CAS: 226566-43-4
RWJ-445167 (3DP-10017) (3DP-10017) 是凝血酶和因子 Xa 的双重抑制剂,Ki 分别为 4.0 nM 和 230 nM,具有有效的抗血栓形成活性。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10277 | PPACK Dihydrochloride | - | >98.00% | |
PPACK是一种有效的选择性和不可逆凝血酶抑制剂,能够抑制人α凝血酶,Ki值为0.24 nM。 | ||||
| GC10448 | Bivalirudin Trifluoroacetate | 128270-60-0 | - | |
A thrombin inhibitor | ||||
| GC11101 | 5-R-Rivaroxaban | 865479-71-6 | >99.50% | |
5-R-Rivaroxaban 是 Rivaroxaban 的 (R)-对映异构体。 | ||||
| GC11644 | Edoxaban | 480449-70-5 | >98.00% | |
Edoxaban (DU-176b) 是一种具有口服活性、高效、选择性和直接的因子 Xa (FXa) 抑制剂,对游离人 FXa 和凝血酶原酶的 Ki 值分别为 0.561 和 2.98 nM。 | ||||
| GC12839 | Edoxaban tosylate monohydrate | 1229194-11-9 | >99.50% | |
A potent inhibitor of Factor Xa | ||||
| GC12875 | Dabigatran ethyl ester | 429658-95-7 | >98.00% | |
达比加群乙酯是一种新兴的口服抗凝剂,是凝血酶活性的直接抑制剂。 | ||||
| GC15180 | BIBR-1048 | 211915-06-9 | >99.50% | |
A prodrug form of dabigatran | ||||
| GC15390 | Dabigatran etexilate mesylate | 872728-81-9 | >98.00% | |
A prodrug form of dabigatran | ||||
| GC16293 | BIBR 953 (Dabigatran, Pradaxa) | 211914-51-1 | >98.50% | |
A thrombin inhibitor | ||||
| GC10140 | Thrombin Receptor Agonist Peptide | 137339-65-2 | - | |
A peptide agonist of the α-thrombin receptor | ||||
| GC10398 | Heparin sodium | 9041-08-1 | >98.00% | |
肝素钠作为抗凝剂,属于一类葡聚糖,可与多种蛋白质相互作用,产生多种生物活性。 | ||||
| GC11672 | Argatroban | 74863-84-6 | - | |
A thrombin inhibitor | ||||
| GC13130 | Apixaban | 503612-47-3 | >99.50% | |
An inhibitor of Factor Xa | ||||
| GC14502 | AEBSF.HCl | 30827-99-7 | >99.50% / >98.50% / >98.00% / >99.00% | |
AEBSF.HCl是丝氨酸蛋白酶广谱的不可逆的抑制剂,可抑制胰凝乳蛋白酶,激肽释放酶,纤溶酶,凝血酶,胰蛋白酶和相关的溶栓酶等。 | ||||
| GC17362 | Metolazone | 17560-51-9 | >99.50% | |
A thiazide-like diuretic | ||||
| GC17423 | TS 155-2 | 1314486-37-7 | >95.00% | |
An antihypertensive antibiotic | ||||
| GC17726 | Otamixaban | 193153-04-7 | >98.50% | |
Otamixaban(FXV673) 是一种有效的 (Ki = 0.5 nM)、选择性、快速作用、竞争性和可逆的 fXa 抑制剂,可有效抑制游离和凝血酶原结合的 fXa。 | ||||
| GC18249 | NQ301 | 130089-98-4 | >98.50% | |
A naphthoquinone with diverse biological activities | ||||
| GC19766 | Heparin sodium salt (MW 15kDa) | 9041-08-1 | >99.50% | |
肝素钠盐(MW 15kDa)(Sodium heparin (MW 15kDa))是肝素的聚合物,分子量为15kDa。 | ||||
| GC32554 | Inogatran (H-314-27) | 155415-08-0 | - | |
Inogatran (H-314-27) (H-314-27) 是一种合成凝血酶抑制剂,用于治疗和预防动脉和静脉血栓性疾病。 | ||||
| GC32567 | RWJ-445167 (3DP-10017) | 226566-43-4 | - | |
RWJ-445167 (3DP-10017) (3DP-10017) 是凝血酶和因子 Xa 的双重抑制剂,Ki 分别为 4.0 nM 和 230 nM,具有有效的抗血栓形成活性。 | ||||
| GC32619 | OM-189 | 55381-18-5 | - | |
OM-189是一种人工合成且有选择性的凝血酶抑制剂。 | ||||
| GC32639 | Thrombin inhibitor 1 | 855998-46-8 | - | |
Thrombininhibitor1是一种有效的凝血酶抑制剂(Ki=0.66nM,2xaPTT=0.43μM)。 | ||||
| GC32663 | Desethyl KBT-3022 | 101001-72-3 | - | |
DesethylKBT-3022是新型抗血小板药物KBT-3022的主要活性代谢物。 | ||||
